A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 33, Issue 2, Pages 165-175
Publisher
Oxford University Press (OUP)
Online
2011-07-31
DOI
10.1093/eurheartj/ehr239
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Polymorphism of the β1 Adrenoreceptor and CYP2D6 on the Therapeutic Effects of Metoprolol
- (2013) H Yuan et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines
- (2011) J J Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Relation of Baseline High-Sensitivity C-Reactive Protein Level to Cardiovascular Outcomes With Rosuvastatin in the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)
- (2010) Paul M. Ridker et al. AMERICAN JOURNAL OF CARDIOLOGY
- Clopidogrel Resistance
- (2010) Jaya Prakash Sugunaraj et al. AMERICAN JOURNAL OF THERAPEUTICS
- Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patients
- (2010) Morten Petersen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
- (2010) Dirk Sibbing et al. CIRCULATION
- A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African Americans
- (2010) D Voora et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease
- (2010) Jasper Jan Brugts et al. EUROPEAN HEART JOURNAL
- KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study
- (2010) Olga A. Iakoubova et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- VKORC1 −1639G>A and CYP2C9*3 are the major genetic predictors of phenprocoumon dose requirement
- (2010) Helene Puehringer et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Review Article: Combination of Clopidogrel and Proton Pump Inhibitors: Implications for Clinicians
- (2010) Marie Tran et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lack of Association Between the Trp719Arg Polymorphism in Kinesin-Like Protein-6 and Coronary Artery Disease in 19 Case-Control Studies
- (2010) Themistocles L. Assimes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
- (2010) Jessica L Mega et al. LANCET
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- Genome-wide association studies in pharmacogenomics
- (2010) Ann K. Daly NATURE REVIEWS GENETICS
- Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment
- (2010) Guillaume Paré et al. NEW ENGLAND JOURNAL OF MEDICINE
- Haplotypes of the adrenergic system predict the blood pressure response to β-blockers in women with essential hypertension
- (2010) Fabiana Filigheddu et al. PHARMACOGENOMICS
- Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations
- (2010) Mathew J. Barber et al. PLoS One
- Gln27→Gluβ2-Adrenergic Receptor Polymorphism in Heart Failure Patients: Differential Clinical and Oxidative Response to Carvedilol
- (2009) Rodrigo Troncoso et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)
- (2009) Frederick G. Kushner et al. CIRCULATION
- Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
- (2009) Jessica L. Mega et al. CIRCULATION
- Heart Disease and Stroke Statistics—2010 Update
- (2009) et al. CIRCULATION
- Comprehensive Whole-Genome and Candidate Gene Analysis for Response to Statin Therapy in the Treating to New Targets (TNT) Cohort
- (2009) John F. Thompson et al. Circulation-Cardiovascular Genetics
- The genetics of antiplatelet drug resistance
- (2009) G Feher et al. CLINICAL GENETICS
- Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail Inpatients
- (2009) E Pautas et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics of Oral Anticoagulant Therapy
- (2009) T. Schalekamp et al. CURRENT PHARMACEUTICAL DESIGN
- A genome-wide association study of acenocoumarol maintenance dosage
- (2009) Martina Teichert et al. HUMAN MOLECULAR GENETICS
- Pharmacogenetic Testing for Clopidogrel Using the Rapid INFINITI Analyzer
- (2009) Patrick Gladding et al. JACC-Cardiovascular Interventions
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clopidogrel Resistance: Pharmacokinetic or Pharmacogenetic?
- (2009) Neville F. Ford JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin
- (2009) Kirsten Neudoerffer Kangelaris et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Pharmacogenetics in Cardiovascular Antithrombotic Therapy
- (2009) Francisco Marín et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Besides CYP2C19*2, the variant allele CYP2C9*3 is associated with higher on-clopidogrel platelet reactivity in patients on dual antiplatelet therapy undergoing elective coronary stent implantation
- (2009) Ankie Harmsze et al. Pharmacogenetics and Genomics
- Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations
- (2009) Kyle J Ellis et al. PHARMACOGENOMICS
- Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform
- (2009) Tristan M Sissung et al. PHARMACOGENOMICS
- APOE gene polymorphisms and response to statin therapy
- (2009) E Zintzaras et al. PHARMACOGENOMICS JOURNAL
- Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement— A systematic review and meta analysis
- (2009) Limei Yang et al. THROMBOSIS RESEARCH
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- The largest prospective warfarin-treated cohort supports genetic forecasting
- (2008) M. Wadelius et al. BLOOD
- A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
- (2008) G. M. Cooper et al. BLOOD
- Pharmacogenetics of aspirin resistance: a comprehensive systematic review
- (2008) Timothy Goodman et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
- (2008) BF Gage et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics: From Bench to Byte
- (2008) JJ Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β-Blocker Users
- (2008) MJ Bijl et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in Hypertension
- (2008) MA Pacanowski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of the CYP2D6 Genotype on the Clinical Effects of Metoprolol: A Prospective Longitudinal Study
- (2008) T Rau et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin
- (2008) Elena Piazuelo et al. CLINICAL THERAPEUTICS
- CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction
- (2008) J. J. Regieli et al. EUROPEAN HEART JOURNAL
- Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation
- (2008) et al. EUROPEAN HEART JOURNAL
- Influence of CYP2C9 genotype on warfarin dose requirements—a systematic review and meta-analysis
- (2008) Jonatan D. Lindh et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Ile164 variant of β2-adrenoceptor does not influence outcome in heart failure but may interact with β blocker treatment
- (2008) Mathew D. Littlejohn et al. EUROPEAN JOURNAL OF HEART FAILURE
- Role of β adrenergic receptor polymorphisms in heart failure: Systematic review and meta-analysis
- (2008) Amal Muthumala et al. EUROPEAN JOURNAL OF HEART FAILURE
- Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene
- (2008) Peter Staritz et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response
- (2008) Patrick Gladding et al. JACC-Cardiovascular Interventions
- Association between a TGFβ1 promoter polymorphism and the phenotype of aspirin-intolerant chronic urticaria in a Korean population
- (2008) H.-J. Park et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Association of TNF-α promoter polymorphisms with aspirin-induced urticaria
- (2008) J. H. Choi et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents
- (2008) Dietmar Trenk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of the Trp719Arg Polymorphism in Kinesin-Like Protein 6 With Myocardial Infarction and Coronary Heart Disease in 2 Prospective Trials
- (2008) Olga A. Iakoubova et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Polymorphism in KIF6 Gene and Benefit From Statins After Acute Coronary Syndromes
- (2008) Olga A. Iakoubova et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Common variants at 30 loci contribute to polygenic dyslipidemia
- (2008) Sekar Kathiresan et al. NATURE GENETICS
- Newly identified loci that influence lipid concentrations and risk of coronary artery disease
- (2008) Cristen J Willer et al. NATURE GENETICS
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease
- (2008) Tuomo Nieminen et al. PHARMACOGENOMICS
- CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation
- (2008) Tobias Geisler et al. PHARMACOGENOMICS
- Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use
- (2008) Felix W Frueh et al. PHARMACOTHERAPY
- 2007 Update to the ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Implications for Emergency Department Practice
- (2007) Charles V. Pollack et al. ANNALS OF EMERGENCY MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More